all report title image

RECOMBINANT DNA TECHNOLOGY MARKET ANALYSIS

Recombinant Dna Technology Market, By Product Type (Recombinant Protein Drugs, Vaccines , Genetically Modified Crops, Cell and Gene Therapy, and Gene Editing), By Application (Therapeutics, Agriculture, Research, and Others), By End User (Biotechnology and Pharmaceutical Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024
Code : CMI893
Pages :183
Formats :
Excel and PDF
Industry : Biotechnology

Market Concentration and Competitive Landscape

Recombinant Dna Technology Market Concentration By Players

To learn more about this report, request sample copy

Key Players Insights

Thermo Fisher Scientific, Inc.
Biogen, Inc.
Sanofi
Pfizer, Inc.
Amgen, Inc.
Merck & Co., Inc.
Profacgen
Monsanto Company
Genentech Inc.
Eli Lilly and Company
Janssen Pharmaceuticals Inc.
GSK plc.
Jiangsu Recbio Technology Co., Ltd.
New England Biolabs
GenScript
Lonza
ProteoGenix

Recombinant Dna Technology Market Report Snapshots

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Press Release

Recombinant Dna Technology Market to Surpass US$ 327.63 Bn by 2031

Credibility and Certifications

ESOMAR

DUNS Registered

Clutch

DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.